Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527146 · ClinicalTrials.gov registry record · NA
GEnetic Counseling Through Virtual Visits in Parkinson's Disease
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 370
- Enrollment target
NCT04527146: Completed NA study, sponsored by University of Pennsylvania.
NCT04527146 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 370 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04527146, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
Study Summary
The research study is being conducted to compare methods of virtual genetic counseling for people with Parkinson's disease.
Primary Outcome
Genetics Knowledge Scale (20-question true/false questionnaire, score range 0-20, higher scores mean greater knowledge)
Interventions
- OTHER IMAGINE-PD
- OTHER Virtual genetic counseling
- OTHER Telephone genetic counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT04527146 record still lists
NCT04527146 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which IMAGINE-PD is the first listed.
NCT04527146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04527146 about?
NCT04527146 is a clinical study titled "GEnetic Counseling Through Virtual Visits in Parkinson's Disease". The research study is being conducted to compare methods of virtual genetic counseling for people with Parkinson's disease.
What is the current status of trial NCT04527146?
This trial is currently completed. It is a NA study. The enrollment target is 370 participants. The study started on 2021-01-01. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT04527146?
The interventions under investigation include: IMAGINE-PD (OTHER), Virtual genetic counseling (OTHER), Telephone genetic counseling (OTHER).
Who is sponsoring clinical trial NCT04527146?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04527146's enrollment target sits among peer trials
370 281st of 2000 higher than 1,720 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI